Skip to main content
Erschienen in: Rheumatology International 11/2008

01.09.2008 | Review

Paget’s disease of bone: a review

verfasst von: Matteo Colina, Renato La Corte, Francesco De Leonardis, Francesco Trotta

Erschienen in: Rheumatology International | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

Paget’s disease of bone (PDB) is a condition of unknown etiology characterized by excessive and abnormal bone remodeling. It may be localized to one or several skeletal segments. The disease seldom appears before the age of 40 years, but its prevalence tends to double each decade from the age of 50 onwards, reaching about 10% after ninth decade. PDB may virtually affect every bone in the skeleton. Affected bones are involved right away with no new involvement during the evolution. The basic symptom of the disease is bone pain, while complications depend on skeletal sites involved and range from secondary osteoarthritis to malignant degeneration. Diagnosis is usually based upon clinical features, imaging, and laboratory analyses. Therapeutic approach is currently based on second-generation bisphosphonates. Their use is recommended when bone alkaline phosphatase is high and/or when the disease localizations are highly suspected for determining complications.
Literatur
1.
Zurück zum Zitat Nagant de Deuxchaisnes C, Krane SM (1964) Paget’s disease of bone. Clinical and metabolic observations. Medicine 43:233–266 Nagant de Deuxchaisnes C, Krane SM (1964) Paget’s disease of bone. Clinical and metabolic observations. Medicine 43:233–266
2.
Zurück zum Zitat Roberts C, Manchester K (1995) The archeology of disease. Sutton Publishing, Phoenix Mill Roberts C, Manchester K (1995) The archeology of disease. Sutton Publishing, Phoenix Mill
3.
Zurück zum Zitat Barker DJ, Clough PW, Guyer PB, Gardner MJ (1977) Paget’s disease of bone in 14 British towns. BMJ 1:1181–1183PubMed Barker DJ, Clough PW, Guyer PB, Gardner MJ (1977) Paget’s disease of bone in 14 British towns. BMJ 1:1181–1183PubMed
4.
Zurück zum Zitat Barker DJ, Chamberlain AT, Guyer PB, Gardner MJ (1980) Paget’s disease of bone: the Lancashire focus. BMJ 280:1105–1107PubMed Barker DJ, Chamberlain AT, Guyer PB, Gardner MJ (1980) Paget’s disease of bone: the Lancashire focus. BMJ 280:1105–1107PubMed
5.
Zurück zum Zitat Gardner MJ, Guyer PB, Barker DJ (1978) Radiological prevalence of Paget’s disease of bone in British migrants to Australia. BMJ 1:1665–1657 Gardner MJ, Guyer PB, Barker DJ (1978) Radiological prevalence of Paget’s disease of bone in British migrants to Australia. BMJ 1:1665–1657
8.
Zurück zum Zitat Detheridge FM, Guyer PB, Barker DJP (1982) European distribution of Paget’s disease of bone. Br Med J (Clin Res Ed) 285:1005–1008 Detheridge FM, Guyer PB, Barker DJP (1982) European distribution of Paget’s disease of bone. Br Med J (Clin Res Ed) 285:1005–1008
9.
Zurück zum Zitat Bhadada S, Bhansali A, Unnikrishnan AG, Khadgawat R, Singh SK, Mithal A et al (2006) Does Paget’s disease of bone exist in India? A report of 21 patients. J Assoc Physicians India 54:530–534PubMed Bhadada S, Bhansali A, Unnikrishnan AG, Khadgawat R, Singh SK, Mithal A et al (2006) Does Paget’s disease of bone exist in India? A report of 21 patients. J Assoc Physicians India 54:530–534PubMed
10.
14.
Zurück zum Zitat Kanis JA (1988) Pathophysiology and treatment of Paget’s disease of bone, 2nd edn. Martin Dunitz, London Kanis JA (1988) Pathophysiology and treatment of Paget’s disease of bone, 2nd edn. Martin Dunitz, London
15.
Zurück zum Zitat Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G (1995) Frequency and characteristics of familial aggregation of Paget’s disease of bone. J Bone Miner Res 10:663–670PubMed Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G (1995) Frequency and characteristics of familial aggregation of Paget’s disease of bone. J Bone Miner Res 10:663–670PubMed
16.
Zurück zum Zitat Sofaer JA, Holloway SM, Emery AE (1983) A family study of Paget’s disease of bone. J Epidemiol Community Health 37:226–231PubMedCrossRef Sofaer JA, Holloway SM, Emery AE (1983) A family study of Paget’s disease of bone. J Epidemiol Community Health 37:226–231PubMedCrossRef
21.
Zurück zum Zitat Singer FR (1999) Update on the viral etiology of Paget’s disease of bone. J Bone Miner Res 14:S29–S33 Singer FR (1999) Update on the viral etiology of Paget’s disease of bone. J Bone Miner Res 14:S29–S33
22.
Zurück zum Zitat Reddy SV, Singer FR, Roodman GD (1995) Bone marrow mononuclear cells from patients with Paget’s disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 80:2108–2111. doi:10.1210/jc.80.7.2108 PubMedCrossRef Reddy SV, Singer FR, Roodman GD (1995) Bone marrow mononuclear cells from patients with Paget’s disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 80:2108–2111. doi:10.​1210/​jc.​80.​7.​2108 PubMedCrossRef
24.
Zurück zum Zitat Layfield R, Cavey JR, Najat D, Long J, Sheppard PW, Ralston SH et al (2006) P62 mutations, ubiquitin recognition and Paget’s disease of bone. Biochem Soc Trans 34:735–737. doi:10.1042/BST0340735 PubMedCrossRef Layfield R, Cavey JR, Najat D, Long J, Sheppard PW, Ralston SH et al (2006) P62 mutations, ubiquitin recognition and Paget’s disease of bone. Biochem Soc Trans 34:735–737. doi:10.​1042/​BST0340735 PubMedCrossRef
25.
Zurück zum Zitat Lucas GJA, Daroszewska A, Ralston SH (2007) Contribution of genetic factors to the pathogenesis of Paget’s disease of bone and related disorders. J Bone Miner Res 21:31–P37. doi:10.1359/jbmr.06s206 CrossRef Lucas GJA, Daroszewska A, Ralston SH (2007) Contribution of genetic factors to the pathogenesis of Paget’s disease of bone and related disorders. J Bone Miner Res 21:31–P37. doi:10.​1359/​jbmr.​06s206 CrossRef
26.
Zurück zum Zitat Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG et al (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45–48. doi:10.1038/71667 PubMedCrossRef Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG et al (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45–48. doi:10.​1038/​71667 PubMedCrossRef
27.
Zurück zum Zitat Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget’s disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissues. Arthritis Rheum 23:1095–1103. doi:10.1002/art.1780231005 PubMedCrossRef Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget’s disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissues. Arthritis Rheum 23:1095–1103. doi:10.​1002/​art.​1780231005 PubMedCrossRef
31.
Zurück zum Zitat Maldague B, Malghem J (1989) Medical imaging of Paget’s disease. Rev Prat 39:1113–1124PubMed Maldague B, Malghem J (1989) Medical imaging of Paget’s disease. Rev Prat 39:1113–1124PubMed
32.
Zurück zum Zitat Mirra JM, Brien EW, Tehranzadeh J (1995) Paget’s disease of bone: review with emphasis on radiologic features, part I. Skeletal Radiol 24:163–171PubMed Mirra JM, Brien EW, Tehranzadeh J (1995) Paget’s disease of bone: review with emphasis on radiologic features, part I. Skeletal Radiol 24:163–171PubMed
36.
Zurück zum Zitat Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnick CS, Gannon FH (2002) From the archives of the AFIP. Radiologic spectrum of Paget’s disease of bone and its complications with pathologic correlation. Radiographics 22:1191–1216PubMed Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnick CS, Gannon FH (2002) From the archives of the AFIP. Radiologic spectrum of Paget’s disease of bone and its complications with pathologic correlation. Radiographics 22:1191–1216PubMed
37.
Zurück zum Zitat Moser RP Jr, Vinh TN, Ros PR, Smirniotopoulos JG, Madewell JE, Berrey BH (1987) Paget disease of the anterior tibial tubercle. Radiology 164:211–214PubMed Moser RP Jr, Vinh TN, Ros PR, Smirniotopoulos JG, Madewell JE, Berrey BH (1987) Paget disease of the anterior tibial tubercle. Radiology 164:211–214PubMed
39.
Zurück zum Zitat Papapoulos SE, Frolich M, Mudde AH, Harinck HIJ, Berg HVD, Bijvoet OLM (1987) Serum osteocalcin in Paget’s disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocrinol Metab 65:89–94PubMed Papapoulos SE, Frolich M, Mudde AH, Harinck HIJ, Berg HVD, Bijvoet OLM (1987) Serum osteocalcin in Paget’s disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocrinol Metab 65:89–94PubMed
40.
Zurück zum Zitat Alvarez L, Peris P, Pons F, Guanabens N, Herranz R, Monegal A et al (1997) Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget’s disease activity. Arthritis Rheum 40:461–468. doi:10.1002/art.1780400312 PubMedCrossRef Alvarez L, Peris P, Pons F, Guanabens N, Herranz R, Monegal A et al (1997) Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget’s disease activity. Arthritis Rheum 40:461–468. doi:10.​1002/​art.​1780400312 PubMedCrossRef
41.
42.
Zurück zum Zitat Alvarez L, Guanabens N, Peris P, Monegal A, Bedini JL, Deulofeu R et al (1997) Discriminating value of biochemical markers of bone turnover in assessing the activity of Paget’s disease. J Bone Miner Res 10:458–465CrossRef Alvarez L, Guanabens N, Peris P, Monegal A, Bedini JL, Deulofeu R et al (1997) Discriminating value of biochemical markers of bone turnover in assessing the activity of Paget’s disease. J Bone Miner Res 10:458–465CrossRef
45.
Zurück zum Zitat Siris ES, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A et al (1996) Comparative study of alendronate vs etidronate for the treatment of Paget’s disease of bone. J Clin Endocrinol Metab 81:961–967. doi:10.1210/jc.81.3.961 PubMedCrossRef Siris ES, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A et al (1996) Comparative study of alendronate vs etidronate for the treatment of Paget’s disease of bone. J Clin Endocrinol Metab 81:961–967. doi:10.​1210/​jc.​81.​3.​961 PubMedCrossRef
46.
Zurück zum Zitat Reid I, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA et al (1996) Biochemical and radiologic improvement in Paget’s disease of bone treated with alendronate. A randomized placebo-controlled trial. Am J Med 101:341–348. doi:10.1016/S0002-9343(96)00227-6 PubMedCrossRef Reid I, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA et al (1996) Biochemical and radiologic improvement in Paget’s disease of bone treated with alendronate. A randomized placebo-controlled trial. Am J Med 101:341–348. doi:10.​1016/​S0002-9343(96)00227-6 PubMedCrossRef
47.
Zurück zum Zitat Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ (1999) A prospective, multicenter, randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget’s disease of bone. Am J Med 106:513–520. doi:10.1016/S0002-9343(99)00062-5 PubMedCrossRef Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ (1999) A prospective, multicenter, randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget’s disease of bone. Am J Med 106:513–520. doi:10.​1016/​S0002-9343(99)00062-5 PubMedCrossRef
48.
Zurück zum Zitat Trombetti A, Arlot M, Thevenon J, Uebelhart B, Meunier PJ (1999) Effects of multiple intravenous pamidronate courses in Paget’s disease of bone. Rev Rhum Engl Ed 66:467–476PubMed Trombetti A, Arlot M, Thevenon J, Uebelhart B, Meunier PJ (1999) Effects of multiple intravenous pamidronate courses in Paget’s disease of bone. Rev Rhum Engl Ed 66:467–476PubMed
49.
Zurück zum Zitat Reid IR, Miller P, Lyles K, Fraser W, Brown J, Saidi Y et al (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med 353:898–908. doi:10.1056/NEJMoa044241 PubMedCrossRef Reid IR, Miller P, Lyles K, Fraser W, Brown J, Saidi Y et al (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med 353:898–908. doi:10.​1056/​NEJMoa044241 PubMedCrossRef
Metadaten
Titel
Paget’s disease of bone: a review
verfasst von
Matteo Colina
Renato La Corte
Francesco De Leonardis
Francesco Trotta
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 11/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0640-6

Weitere Artikel der Ausgabe 11/2008

Rheumatology International 11/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.